rs121913500
|
|
Glioblastoma
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913500
|
|
Glioblastoma
|
A |
0.800 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913500
|
|
Astrocytoma
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913500
|
|
Astrocytoma
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
IDH1 R132H mutations occur in approximately 70% of astrocytomas and oligodendroglial tumors.
|
19798509 |
2009 |
rs121913500
|
|
Astrocytoma
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Furthermore, IMab-1 specifically stained the IDH1(R132H)-expressing cells in astrocytomas in immunohistochemistry, whereas it did not react with IDH1(R132H)-negative primary glioblastoma sections.
|
19818334 |
2009 |
rs121913500
|
|
Brain Neoplasms
|
T |
0.790 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913500
|
|
Brain Neoplasms
|
A |
0.790 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913500
|
|
Brain Neoplasms
|
T |
0.790 |
GeneticVariation
|
CLINVAR |
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.
|
23558169 |
2013 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
A |
0.760 |
CausalMutation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
T |
0.760 |
CausalMutation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
T |
0.760 |
CausalMutation
|
CLINVAR |
Molecular evaluation of DNMT3A and IDH1/2 gene mutation: frequency, distribution pattern and associations with additional molecular markers in normal karyotype Indian acute myeloid leukemia patients.
|
24606448 |
2014 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
T |
0.760 |
CausalMutation
|
CLINVAR |
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
|
22417203 |
2012 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
T |
0.760 |
CausalMutation
|
CLINVAR |
The role of mutations in epigenetic regulators in myeloid malignancies.
|
22898539 |
2012 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
G |
0.760 |
CausalMutation
|
CLINVAR |
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
|
22417203 |
2012 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
A |
0.760 |
CausalMutation
|
CLINVAR |
The role of mutations in epigenetic regulators in myeloid malignancies.
|
22898539 |
2012 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
T |
0.760 |
CausalMutation
|
CLINVAR |
Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.
|
22397365 |
2012 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
A |
0.760 |
CausalMutation
|
CLINVAR |
Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.
|
22397365 |
2012 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
G |
0.760 |
CausalMutation
|
CLINVAR |
The role of mutations in epigenetic regulators in myeloid malignancies.
|
22898539 |
2012 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
A |
0.760 |
CausalMutation
|
CLINVAR |
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
|
22417203 |
2012 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
A |
0.760 |
CausalMutation
|
CLINVAR |
Impact of genetic features on treatment decisions in AML.
|
22160010 |
2011 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
G |
0.760 |
CausalMutation
|
CLINVAR |
Impact of genetic features on treatment decisions in AML.
|
22160010 |
2011 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
T |
0.760 |
CausalMutation
|
CLINVAR |
Impact of genetic features on treatment decisions in AML.
|
22160010 |
2011 |
rs121913500
|
|
Leukemia, Myelocytic, Acute
|
T |
0.760 |
CausalMutation
|
CLINVAR |
Recurring mutations found by sequencing an acute myeloid leukemia genome.
|
19657110 |
2009 |
rs121913500
|
|
MYELODYSPLASTIC SYNDROME
|
T |
0.710 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913500
|
|
MYELODYSPLASTIC SYNDROME
|
A |
0.710 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |